Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000617654 | SCV000737326 | uncertain significance | Cardiovascular phenotype | 2017-11-15 | criteria provided, single submitter | clinical testing | The p.T1166S variant (also known as c.3497C>G), located in coding exon 32 of the MYBPC3 gene, results from a C to G substitution at nucleotide position 3497. The threonine at codon 1166 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |